Dose Escalation Study of Kylo-0603 in Healthy Subjects

NCT06365580 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Steatohepatitis

Interventions

DRUG: Kylo-0603 capsule
DRUG: Placebo

Sponsor

Kylonova (Xiamen) Biopharma co., LTD.